Ibuprofen will now be tested as coronavirus treatment

Source

What if the answer to treating the coronavirus was in our medicine cabinets all along?

Despite early speculation that ibuprofen was exacerbating coronavirus symptoms, a later study found that those negative side effects could not be attributed to the common anti-inflammatory drug.

Now, some scientists think that ibuprofen may, in fact, be an effective defense against COVID-19, according to the US National Library of Medicine’s clinical trials database.

Doctors from London’s Guy’s and St. Thomas’ hospital and King’s College are beginning clinical research on patients in a trial program dubbed “Liberate,” wherein half of the test subjects will be treated with ibuprofen while the other half will receive treatment without the added drug.

Scientists note that they will be using a unique formulation that wouldn’t be found in drugstores; rather, it’s in lipid capsule form that’s prescribed for conditions such as arthritis.

Findings in animal studies have suggested that ibuprofen could treat acute respiratory distress syndrome, which is known to develop in coronavirus patients.

“We need to do a trial to show that the evidence actually matches what we expect to happen,” says professor Mitul Mehta of King’s College London.

The idea that ibuprofen may lead to severe coronavirus complications was inspired by a report in March of a 4-year-old British child whose symptoms worsened after taking the fever-reducing drug. This prompted the UK’s health officials to rescind recommendations for taking ibuprofen to treat symptoms. Later the French health minister Olivier Véran bolstered the claim when he said the drug could “aggravate the infection.”

This prompted King’s College London researchers to conduct a review of 13 previous studies about ibuprofen, but ultimately they found no evidence that it had the potential to weaken the immune system. They published their report in the journal Ecancermedicalscience on March 27.

“Our search did not identify any strong evidence for or against the use of ibuprofen for treatment of COVID-19 specifically,” the study reads. “The current literature does not give conclusive evidence for or against the use of NSAIDs in the treatment of COVID-19 patients.”

nypost.com

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related News

Are you able to catch the coronavirus from a swimming pool?

Source Elements of America are already baking, although summer time doesn’t formally arrive for an additional two weeks. So with the warmth on, all people desires...

The heroic tales of the forgotten victims of the Titanic

Source In the summertime of 1912, weeks after the Titanic sank along with her furnace-stoker husband, William, on board, his impoverished widow, Emily Bessant, heard...

How one can watch strawberry moon 2020, which comes with a penumbral lunar eclipse

Source Friday’s evening sky is about to host a full “strawberry” moon in partial penumbral eclipse in some elements of the world. North Individuals who need...

Ankle weights are cool once more, because of Instagram

Source Like bike shorts and high-waisted mother denims earlier than them, one other craze of the ’80s and ’90s has returned. With group workouts off the...

World hits new report excessive for degree of heat-trapping carbon dioxide in air

Source KENSINGTON, Maryland — The world hit one other new report excessive for heat-trapping carbon dioxide within the environment, regardless of lowered emissions due to...